Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonova Holding AG Unsponsored ADR (SONVY)
OTHER OTC:SONVY
Holding SONVY?
Track your performance easily
Earnings Data
Report Date
May 20, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
1.42Last Year’s EPS
1.29Same Quarter Last Year
Moderate Sell
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 21, 2019
|% Change Since: -1.82%
|Next Earnings Date:Nov 20, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view with strong product launch feedback and solid sales growth, particularly in cochlear implants, but faced profitability pressures and challenging market conditions, especially in the Audiological Care segment.Company Guidance
During the Sonova Holding AG Half Year Results 2024-2025 Conference Call, the company provided guidance confirming expectations for both top-line and bottom-line growth for the fiscal year. They reported a solid sales growth of 5.9% in local currencies, primarily driven by a 7% increase in the Hearing Instruments segment and a 12.5% growth in Cochlear Implants. The new Sphere and Infinio products, launched in August and September, received positive feedback, contributing to a strong momentum anticipated to carry into the second half of the year. The company acknowledged challenges such as market conditions, lead generation costs, and headwinds from the Swiss franc. However, they expressed confidence in achieving their guidance, supported by structural cost improvements, and strategic initiatives expected to enhance operating efficiency and profitability. Sonova highlighted a projected uplift in ASP (Average Selling Price) contributing positively to EBITDA growth, alongside incremental volume increases.Solid Sales Growth
Sonova Holding AG reported a solid sales growth of 5.9% in local currencies for the first half of fiscal year 2024-2025, driven by hearing instruments and cochlear implants.
Cochlear Implant Segment Performance
The cochlear implant business showed strong momentum with a 12.5% growth for the first half of the fiscal year, with system sales up by 18.2%.
Positive Product Launch Feedback
The launch of Infinio and Sphere received very positive feedback, with a high share of Sphere Infinio supporting strong ASP uplift.
---
SONVY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SONVY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 19, 2024 | $71.56 | $68.11 | -4.82% |
| May 14, 2024 | $58.54 | $62.51 | +6.78% |
| Nov 21, 2023 | $52.38 | $55.31 | +5.59% |
| May 16, 2023 | $60.94 | $54.39 | -10.75% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Sonova Holding AG Unsponsored ADR (SONVY) report earnings?
Sonova Holding AG Unsponsored ADR (SONVY) is schdueled to report earning on May 20, 2025, TBA Not Confirmed.
What is Sonova Holding AG Unsponsored ADR (SONVY) earnings time?
Sonova Holding AG Unsponsored ADR (SONVY) earnings time is at May 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SONVY EPS forecast?
SONVY EPS forecast for the fiscal quarter 2025 (Q4) is 1.42.
---